MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/diseases14020070

Медицинская библиотека · Diseases (Basel, Switzerland) · 2026

Host Serum Biomarker Signatures in Mycobacteriologically Cured Pulmonary Tuberculosis Patients with Persistent Lung Inflammation on 18F-FDG PET/CT.

Motaung Bongani, Sabeel Solima, Ozturk Mumin, Mafu Trevor S, Shey Muki, Mukasa Sandra L, Wolmarans Karen, Jakoet-Bassier Fareda, Taylor Ashleigh, Mashinyira Antoneta, Kotze Tessa, Thienemann Friedrich, Guler Reto

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Pulmonary inflammation is a widely recognized characteristic of active tuberculosis (TB). Although standard TB treatment is effective, a substantial proportion of mycobacteriologically cured TB patients experience persistent pulmonary inflammation, which can lead to long-term lung impairment, post-tuberculosis lung disease (PTLD) and potentially TB recurrence.

METHODS

We conducted a case-control study to compare host serum biomarker profiles in individuals with minimal (TLG < 50 SUVbw*mL, n = 37) versus extensive (TLG ≥ 50 SUVbw*mL, n = 34) persistent lung inflammation following completion of standard drug-sensitive TB treatment. Lung inflammation was measured by 18F-FDG PET/CT scan using total lung glycolysis (TLG) as a surrogate marker. All participants had negative sputum cultures at four months of TB treatment, and blood samples were collected at treatment completion (month six). A Luminex® multiplex assay performed on the Bio-Plex® 200 platform was used to analyze 48 host serum biomarkers involved in cytokine/chemokine signaling.

RESULTS

Following multiple t-test analysis, fifteen biomarkers were significantly elevated (p < 0.05) in participants with extensive persistent lung inflammation compared to those with minimal inflammation. Among these, 14 demonstrated potential as discriminatory markers, with area under the curve (AUC) values ranging from 0.707 to 0.806, sensitivities ranging from 47.06% to 73.53%, and specificities ranging from 70.27% to 83.78%. Notably, 13 of these 16 candidate biomarkers significantly correlated with TLG values, further supporting their potential clinical utility.

CONCLUSION

We report associations between serum inflammatory mediators and persistent pulmonary inflammation following mycobacterial clearance in TB patients, highlighting their potential as diagnostic biomarkers that could potentially meet the target product profile (TPP) criteria.

Для цитирования: Motaung Bongani, Sabeel Solima, Ozturk Mumin, Mafu Trevor S, Shey Muki, Mukasa Sandra L, Wolmarans Karen, Jakoet-Bassier Fareda, Taylor Ashleigh, Mashinyira Antoneta, Kotze Tessa, Thienemann Friedrich, Guler Reto. Host Serum Biomarker Signatures in Mycobacteriologically Cured Pulmonary Tuberculosis Patients with Persistent Lung Inflammation on 18F-FDG PET/CT.. Diseases (Basel, Switzerland). 2026. DOI: 10.3390/diseases14020070.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.